Clinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear

Launched by TEXAS BONE AND JOINT · Oct 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how effective Incrediwear products are for patients recovering from surgery to repair a torn rotator cuff in the shoulder. The trial aims to understand if these products can help reduce pain, improve movement, and decrease swelling after the surgery. If you are between 18 and 75 years old and are planning to undergo this type of surgery, you might be eligible to participate.

Participants will need to agree to follow up with the study guidelines and sign a consent form. During the trial, you can expect to use Incrediwear products as part of your recovery. However, there are some health conditions that would prevent you from joining, such as certain neurological disorders, severe medical issues, or a history of shoulder surgery in the last five years. This trial is not yet recruiting, but it could provide valuable information on how to enhance recovery after rotator cuff repair.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients undergoing arthroscopic rotator cuff repair
• • 2. Patients aged 18-75
• • 3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
• • 4. Patients who are willing and able to sign corresponding research subject consent form.
• Exclusion Criteria:
• • 1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
• • 2. Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
• • 3. Patient has had prior surgical treatment of a shoulder injury in the past 5 years
• • 4. Patient has chronic pain conditions unrelated to shoulder condition
• • 5. Patient has auto-immune or auto-inflammatory diseases
• • 6. Patient has used tobacco within the last 90 days
• • 7. Patient is not within the ages of 18-75
• • 8. Patient has poorly controlled diabetes with HgA1c \> 7.5
• • 9. Patient has an active infection (local or systemic)
• • 10. Patient is unwilling or unable to sign the corresponding research subject consent form
• • 11. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
• • 12. Against medical advice (AMA)
• • 13. Prisoner as indicated in the medical record